Galapagos and Janssen part ways in inflammation alliance
Seeking Alpha - at Seeking Alpha - Tue Mar 17, 6:58AM CDT
JNJ: 102.06 (+0.73)
Seeking Alpha's Biotech Weekly: Crush-Proof Pfizer, Achillion's HCV Crusher, And More
SA Editor Mike Taylor - Seeking Alpha - Fri Feb 13, 3:00PM CST
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. See something here that deserves further analysis? We are always looking for new...
VRX: 207.50 (+1.78), ACT: 294.79 (+2.52), MDT: 77.93 (+0.80), XON: 42.89 (+0.87), CTIC: 1.93 (+0.02), PFNX: 18.98 (+2.17), JNJ: 102.06 (+0.73), ANTM: 153.92 (+0.43), NVAX: 8.35 (+0.16), SHPG: 248.77 (-5.55), ABBV: 62.00 (+1.68), TBPH: 18.01 (+0.26), SNY: 52.35 (+0.48), ALQA: 4.67 (-0.10), REGN: 461.39 (+6.35), ONCY: 0.70 (-0.02), PFE: 35.44 (+0.41), SLXP: 172.96 (+0.15), EPRS: 8.41 (-0.04), AMGN: 163.38 (+1.89), NKTR: 11.22 (+0.04), ZTS: 47.17 (+0.62), GILD: 101.77 (+0.61), ACHN: 10.36 (+0.14), GERN: 4.08 (+0.12)
Galapagos awarded €1.6M grant to develop Hep B therapies
Seeking Alpha - at Seeking Alpha - Wed Feb 11, 6:44AM CST
Galapagos earns milestone from AbbVie
Seeking Alpha - at Seeking Alpha - Fri Dec 19, 7:09AM CST
ABBV: 62.00 (+1.68)
Molecular Biology Meets Finance: MLV's George Zavoico On Ebola's Silver Lining
Life Sciences Report - Seeking Alpha - Thu Nov 13, 6:59AM CST
A working knowledge of molecular biology is essential for a biotech investor, but it helps when someone with deep knowledge of science and medicine can bring understanding to the people who commit capital to growth ideas. George Zavoico of MLV &...
CERS: 3.90 (+0.03), AGEN: 5.42 (+0.12), NVAX: 8.35 (+0.16), ALXN: 182.68 (+5.31), PPHM: 1.40 (+0.02), THLD: 4.25 (+0.01), GSK: 48.23 (+0.51), OMER: 24.58 (+0.44)
Galapagos - AbbVie's Best Bet For Staying Market Leader In Rheumatoid Arthritis Post Humira?
SNJBiostoxx - at Seeking Alpha - Tue Nov 11, 2:45PM CST
ABBV: 62.00 (+1.68)